Human granulocyte ehrlichiosis in Europe

Clinical Microbiology and Infection

Volumn 8, Issue 12, 2002, Pages 763-772

  Blanco, J R ^a   Oteo, J A ^a  

^a Hospital de La Rioja   (Spain)

Author keywords

Ehrlichia; Ehrlichiosis; Human granulocytic ehrlichiosis

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; CEFTRIAXONE; CHLORAMPHENICOL; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LIVER ENZYME; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TROVAFLOXACIN; BACTERIUM ANTIBODY;

ADULT; AGED; ANAMNESIS; ANAPLASMA; ANAPLASMA PHAGOCYTOPHILUM; ANEMIA; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIUM ISOLATION; BORRELIA BURGDORFERI; CHILD; DISEASE CARRIER; DISEASE SEVERITY; EHRLICHIOSIS; EUROPE; FEMALE; FLU LIKE SYNDROME; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOFLUORESCENCE TEST; IXODES RICINUS; LEUKOPENIA; LIVER FUNCTION TEST; LYME DISEASE; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SLOVENIA; SYMPTOMATOLOGY; THROMBOCYTOPENIA; TICK BITE; TICK BORNE DISEASE; UNITED STATES; ANIMAL; BLOOD; DIFFERENTIAL DIAGNOSIS; FLUORESCENT ANTIBODY TECHNIQUE; GROWTH, DEVELOPMENT AND AGING; IXODES; MICROBIOLOGY; SEROLOGY;

ACARI; ANAPLASMA; ANAPLASMA PHAGOCYTOPHILUM; ANIMALIA; BACTERIA (MICROORGANISMS); BORRELIA; BORRELIA BURGDORFERI; EHRLICHIA; IXODES; IXODES RICINUS; IXODIDAE; NEGIBACTERIA;

ANAPLASMA PHAGOCYTOPHILUM; ANIMALS; ANTIBODIES, BACTERIAL; DIAGNOSIS, DIFFERENTIAL; EHRLICHIOSIS; EUROPE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IXODES; POLYMERASE CHAIN REACTION; SEROLOGIC TESTS; UNITED STATES;

EID: 0036883044     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2002.00557.x     Document Type: Review

References (90)

1. Parola P, Raoult D. Tick-borne bacterial diseases emerging in Europe. Clin Microbiol Infect 2001;7:80-3.
2. Oteo JA. Tick-borne diseases in Spain. Clin Microbiol Infect 2001; 7(suppl 1): 31.
3. Chen S, Dumler JS, Bakken JS, Walker AR. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994; 32: 589.
4. Parola P, Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis 2001; 32: 897-928.
5. Brouqui P. Ehrlichiosis in Europe. In: Raoult D, Brouqui P, eds. Rickettsiae and rickettsial diseases at the turn of the third millenium. Paris: Elsevier, 1999: 220-32.
6. Lotric-Furlan S, Petrovec M, Zupanc TA et al. Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four patients from Slovenia. Clin Infect Dis 1998; 27: 424-8.
7. Arnez M, Petrovec M, Lotric-Furlan S, Zupanc TA, Strle F. First European pediatric case of human granulocytic ehrlichiosis. J Clin Microbiol 2001; 39: 4591-2.
8. Alberdi MP, Walker AR, Paxton EA, Sumption KJ. Natural prevalence of infection with Ehrlichia (Cytoecetes) phagocytophila of Ixodes ricinus ticks in Scotland. Vet Parasitol 1998; 78: 203-13.
9. Barral M, Benedicto L, Gil H et al. Detection of Ehrlichia phagocytophila DNA in Ixodes ricinus from areas in the north of Spain. In: Raoult D, Brouqui P, eds. Rickettsiae and rickettsial diseases at the turn of the third millenium. Paris: Elsevier, 1999: 428-31.
10. Cinco M, Padovan D, Murgia R, Heldtander M, Engvall EO. Detection of HGE agent-like Ehrlichia in Ixodes ricinus ticks in northern Italy by PCR. Wien Klin Wochenschr 1998; 110: 898-900.
11. Guy E, Tasker S, Joynson DH. Detection of the agent of human granulocytic ehrlichiosis (HGE) in UK ticks using polymerase chain reaction. Epidemiol Infect 1998; 121: 681-3.
12. Jenkins A, Kristiansen BE, Allum AG et al. Borrelia burgdorferi sensu lato and Ehrlichia sp. in Ixodes ticks from southern Norway. J Clin Microbiol 2001; 39: 3666-71.
13. Leutenegger CM, Pusterla N, Mislin CN, Weber R, Lutz H. Molecular evidence of coinfection of ticks with Borrelia burgdorferi sensu lato and the human granulocytic ehrlichiosis agent in Switzerland. J Clin Microbiol 1999; 37: 3390-1.
14. Liz JS, Anderes L, Sumner JW et al. PCR detection of granulocytic ehrlichiae in Ixodes ricinus ticks and wild small mammals in western Switzerland. J Clin Microbiol 2000; 38: 1002-7.
15. Ogden NH, Bown K, Horrocks BK, Woldehiwet Z, Bennett M. Granulocytic Ehrlichia infection in Ixodes ticks and mammals in woodlands and uplands of the UK. Med Vet Entomol 1998; 12: 423-9.
16. Oteo JA, Gil H, Barral M et al. Presence of granulocytic ehrlichia in ticks and serological evidence of human infection in La Rioja, Spain. Epidemiol Infect 2001; 127: 353-8.
17. Parola P, Beati L, Cambon M, Brouqui P, Raoult D. Ehrlichial DNA amplified from Ixodes ricinus (Acari: Ixodidae) in France. J Med Entomol 1998; 35: 180-3.
18. Pusterla N, Leutenegger CM, Huder JB, Weber R, Braun U, Lutz H. Evidence of the human granulocytic ehrlichiosis agent in Ixodes ricinus ticks in Switzerland. J Clin Microbiol 1999; 37: 1332-4.
19. Petrovec M, Sumner JW, Nicholson WL et al. Identity of ehrlichial DNA sequences derived from Ixodes ricinus ticks with those obtained from patients with human granulocytic ehrlichiosis in Slovenia. J Clin Microbiol 1999; 37: 209-10.
20. von Stedingk LV, Gürtelschmid M, Hanson HS et al. The human granulocytic ehrlichiosis (HGE) agent in Swedish ticks. Clin Microbiol Infect 1997; 3: 573-4.
21. Bakken JS, Dumler JS, Chen SM, Eckman MR, van Etta LL, Walker DH. Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA 1994; 272: 212-18.
22. Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis 2000; 31: 554-60.
23. Brouqui P, Dumler JS, Lienhard R, Brossard M, Raoult D. Human granulocytic ehrhchiosis in Europe. Lancet 1995; 346: 782-3.
24. Petrovec M, Lotric FS, Zupanc TA et al. Human disease in Europe caused by a granulocytic Ehrlichia species. J Clin Microbiol 1997; 35: 1556-9.
25. Van Dobbenburgh A, Van Dam AP, Fikrig E. Human granulocytic ehrlichiosis in western Europe. N Engl J Med 1999; 340: 1214-16.
26. Oteo JA, Blanco JR, de Artola V, Ibarra V. First report of human granulocytic ehrlichiosis from southern Europe (Spain). Emerg Infect Dis 2000; 6: 430-1.
27. Eliasson I. Ehrlichiosis, human granulocytic-Sweden. www.heathnet.org/programs/promed.html
28. Karlsson U, Bjoersdorff A, Massung RF, Christensson B. Human granulocytic ehrlichiosis-a clinical case in Scandinavia. Scand J Infect Dis 2001; 33: 73-4.
29. Bjoersdorff A, Berglund J, Kristiansen BE, Soderstrom C, Eliasson I. Varying clinical picture and course of human granulocytic ehrlichiosis. Twelve Scandinavian cases of the new tick-borne zoonosis are presented [in Swedish, summary in English]. Lakartidningen 1999; 96: 4200-4
30. Misic-Majerus LJ, Bujic N, Madjaric V, Janes-Poje V. First description of the human granulocytic ehrlichiosis in Croatia. Clin Microbiol Infect 2000; 6(suppl 1): 194-5.
31. Tylewska-Wierzbanowska S, Chmielewski T, Kondrusik M, Hermanowska-Szpakowicz T, Sawicki W, Sulek K. First cases of acute human granulocytic ehrlichiosis in Poland. Eur J Clin Microbiol Infect Dis 2001; 20: 196-8.
32. Laferl H, Hogrefe W, Kock T, Pichler H. A further case of acute human granulocytic ehrlichiosis in Slovenia. Eur J Clin Microbiol Infect Dis 1999; 18: 385-6.
33. Pusterla N, Huder JB, Feige K, Lutz H. Identification of a granulocytic Ehrlichia strain isolated from a horse in Switzerland and comparison with other rickettsiae of the Ehrlichia phagocytophila genogroup. J Clin Microbiol 1998; 36: 2035-7.
34. Stuen S, Olsson EE. Ehrlichia phagocytophila infection in lambs as a post mortem diagnosis. In: Raoult D, Brouqui P, eds. Rickettsiae and rickettsial diseases at the turn of the third millenium. Paris: Elsevier, 1999: 406-11.
35. Bjoersdorff A, Bergström S, Massung R, Haemig PD, Olsen B. Ehrlichia-infected ticks on migrating birds. Emerg Infect Dis 2001; 7: 877-9.
36. Wicki R, Sauter P, Mettler C et al. Swiss Army survey in Switzerland to determine the prevalence of Francisella tularensis, members of the Ehrlichia phagocytophila genogroup, Borrelia burgdorferi sensu lato, and tick-borne encephalitis virus in ticks. Eur J Clin Microbiol Infect Dis 2000; 19: 427-32.
37. Bakken JS, Krueth J, Lund T, Malkovitch D, Asanovich K, Dumler JS. Exposure to deer blood may be a cause of human granulocytic ehrlichiosis. Clin Infect Dis 1996; 23: 198.
38. Bakken JS, Tilden RL, Walls J, Dumler JS. Influence of occupation, pre-existing illness, and chronic medication use on the severity of illness of human granulocytic ehrlichiosis (HGE). In: Raoult D, Brouqui P, eds. Rickettsiae and rickettsial diseases at the turn of the third millenium. Paris: Elsevier, 1999: 195-8.
39. Comer JA, Nicholson WL, Olson JG, Childs JE. Serologic testing for human granulocytic ehrlichiosis at a national referral center. J Clin Microbiol 1999; 37: 558-64.
40. McQuiston JH, Childs JE, Chammberlang ME, Tarbor E. Transmission of tick-borne agents of disease by blood transfusion: a review of known and potential risks in the United States. Transfusion 2000; 40: 274-84.
41. Kalantarpour F, Chowdhury I, Wormser GP, Aguero-Rosenfeld ME. Survival of the human granulocytic ehrlichiosis agent under refrigeration conditions. J Clin Microbiol 2000; 38: 2398-9.
42. Horowitz HW, Kilchevsky E, Haber S et al. Perinatal transmission of the agent of the human granulocytic ehrlichiosis. N Engl J Med 1998; 339: 375-8.
43. Christova IS, Dumler JS. Human granulocytic ehrlichiosis in Bulgaria. Am J Trop Med Hyg 1999; 60: 58-61.
44. Cizman M, Avsic-Zupanc T, Petrovec M, Ruzic-Sabljic E, Pokorn M. Seroprevalence of ehrlichiosis, Lyme borreliosis and tick-borne encephalitis infections in children and young adults in Slovenia. Wien Klin Wochenschr 2000; 112: 842-5.
45. Dumler JS, Dotevall L, Gustafson R, Granstrom M. A population-based seroepidemiologic study of human granulocytic ehrlichiosis and Lyme borreliosis on the west coast of Sweden. J Infect Dis 1997; 175: 720-2.
46. Fingerle V, Goodman JL, Johnson RC, Kurtti TJ, Munderloh UG, Wilske B. Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups. J Clin Microbiol 1997; 35: 3244-7.
47. Lebech AM, Hansen K, Pancholi P, Sloan LM, Magera JM, Persing DH. Immunoserologic evidence of human granulocytic ehrlichiosis in Danish patients with Lyme neuroborreliosis. Scand J Infect Dis 1998; 30: 173-6.
48. Nuti M, Serafini DA, Bassetti D et al. Ehrlichia infection in Italy. Emerg Infect Dis 1998; 4: 663-5.
49. Pusterla N, Weber R, Wolfensberger C et al. Serological evidence of human granulocytic ehrlichiosis in Switzerland. Eur J Clin Microbiol Infect Dis 1998; 17: 207-9.
50. Sumption KJ, Wright DJM, Cutler SJ, Dale BAS. Human ehrlichiosis in the UK. Lancet 1995; 346: 1487-8.
51. Thomas V, Anguita J, Barthold SW, Fikrig E. Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infect Immun 2001; 69: 3359-71.
52. Bakken JS, Krueth J, Tilden RL, Dumler JS, Kristiansen BE. Serological evidence of human granulocytic ehrlichiosis in Norway. Eur J Clin Microbiol Infect Dis 1996; 15: 829-32.
53. Bjoersdorff A, Brouqui P, Eliasson I, Massung RF, Wittesjo B, Berglund J. Serological evidence of Ehrlichia infection in Swedish Lyme borreliosis patients. Scand J Infect Dis 1999; 31: 51-5.
54. Skarphedinsson S, Sogaard P, Pedersen C. Seroprevalence of human granulocytic ehrlichiosis in high-risk groups in Denmark. Scand J Infect Dis 2001; 33: 206-10.
55. Thomas DR, Sillis M, Coleman TJ et al. Low rates of ehrlichiosis and Lyme borreliosis in English farm-workers. Epidemiol Infect 1998; 121: 609-14.
56. Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996; 275: 199-205.
57. Walker DH, Dumler JS. Emergence of the ehrlichioses as human health problems. Emerg Infect Dis 1996; 2: 18-29.
58. Aguero-Rosenfeld ME, Horowitz HW, Wormser GP et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med 1996; 125: 904-8.
59. Wallace BJ, Brady G, Ackman DM et al. Human granulocytic ehrlichiosis in New York. Arch Intern Med 1998; 158: 769-73.
60. Horowitz HW, Aguero-Rosenfeld ME, McKenna DF et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis 1998; 27: 1314-17.
61. Goodman JL, Nelson CM, Vitale B et al. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 1996; 334: 209-15.
62. Ratnasamy N, Everett ED, Roland WE, McDonald G, Caldwell ChW. Central nervous system manifestations of human ehrlichiosis. Clin Infect Dis 1996; 23: 314-19.
63. Jahangir A, Kolbert C, Edwards W, Mitchell P, Dumler JS, Persing DH. Fatal pancarditis associated with human granulocytic ehrlichiosis in a 44-year-old man. Clin Infect Dis 1998; 27: 1424-7.
64. Wong S, Grady LJ. Ehrlichia infection as a cause of severe respiratory distress. N Engl J Med 1996; 334: 273.
65. Bakken JS, Erlemeyer SA, Kanoff RJ, Silvestrini TC, Goodwin DD, Dumler JS. Demyelinating polyneuropathy associated with human granulocytic ehrlichiosis. Clin Infect Dis 1998; 27: 1323-4.
66. Horowitz HW, Marks SJ, Weintraub M, Dumler JS. Brachial plexopathy associated with human granulocytic ehrlichiosis. Neurology 1996; 46: 1026-9.
67. Lee FS, Chu FK, Tackley M, Wu AD, Atri A, Wessels MR. Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year-old woman. Clin Infect Dis 2000; 31: 1288-91.
68. Horowitz HW, Aguero-Rosenfeld ME, Dumler JS et al. Reinfection with the agent of human granulocytic ehrlichiosis. Ann Intern Med 1998; 129: 461-3.
69. Bakken JS, Aguero-Rosenfeld ME, Tilden RL et al. Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis. Clin Infect Dis 2001; 32: 862-70.
70. Centers for Disease Control and Prevention. Case definition conditions under public health surveillance. MMWR Morb Mortal Wkly Rep 1997: 46(RR-10): 46-7.
71. Consensus Workshop on Diagnosis of Human Ehrlichiosis. Am Soc Rickettsiol Newslett 1999; 2: 1-8.
72. Nicholson WL, Comer JA, Sumner JW et al. An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis. J Clin Microbiol 1997; 35: 1510-16.
73. Bakken JS, Haller I, Riddell D, Walls JJ, Dumler JS. The serological response of patients infected with the agent of human granulocytic ehrlichiosis. Clin Infect Dis 2002; 34: 22-7.
74. Lascola B, Raoult D. Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol 1997; 35: 2715-27.
75. Guerrero A, Losada I, de Lucas S, Oteo JA. Ehrlichiosis infection prevalence in Spain or cross reactions. Med Clin (Barc) 2001; 116: 315.
76. Magnarelli L, Dumler JS, Anderson JF, Johnson RC, Fikrig E. Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J Clin Microbiol 1995; 33: 3054-7.
77. Mitchell P, Reed KD, Hofkes JM. Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota. J Clin Microbiol 1996; 34: 724-7.
78. Nadelman RB, Horowitz HW, Hsieh T et al. Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med 1997; 337: 27-30.
79. Weber R, Pusterla N, Loy M, Lutz H. Fever, leukopenia, and thrombocytopenia in a patient with acute Lyme borreliosis were due to human granulocytic ehrlichiosis. Clin Infect Dis 1998; 26: 253-4.
80. Wormser GP, Horowitz HW, Dumler JS, Schwartz I, Aguero-Rosenfeld M. False-positive Lyme disease serology in human granulocytic ehrlichiosis. Lancet 1996; 347: 981-2.
81. Wormser GP, Horowitz HW, Nowakowski J et al. Positive Lyme disease serology in patients with clinical and laboratory evidence of human granulocytic ehrlichiosis. Am J Clin Pathol 1997; 107: 142-7.
82. Bunnell JE, Magnarelli LA, Dumler JS. Infection of laboratory mice with the human granulocytic ehrlichiosis agent does not induce antibodies to diagnostically significant Borrelia burgdorferi antigens. J Clin Microbiol 1999; 37: 2077-9.
83. Massung RF, Slater K, Owens JH et al. Nested PCR assay for detection of granulocytic ehrlichiae. J Clin Microbiol 1998; 36: 1090-5.
84. Inokuma H, Brouqui P, Drancourt M, Raoult D. Citrate synthase gene sequence: a new tool for phylogenetic analysis and identification of ehrlichia. J Clin Microbiol 2001; 39: 3031-9.
85. Garcia-Perez AL, Mandaluniz N, Barral M, Juste RA. Microscopic and PCR findings in sheep after experimental infection with Ehrlichia phagocytophila. Small Ruminant Res 2000; 37: 19-25.
86. Dumler JS. Is human granulocytic ehrlichiosis a new Lyme disease? Review and comparison of clinical, laboratory, epidemiological, and some biological features. Clin Infect Dis 1997; 25(suppl 1): S43-7.
87. Klein MB, Nelson CM, Goodman JL. Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins. Antimicrob Agents Chemother 1997; 41: 76-9.
88. Horowitz HW, Hsieh TC, Aguero-Rosenfeld ME et al. Antimicrobial susceptibility of Ehrlichia phagocytophila. Antimicrob Agents Chemother 2001; 45: 786-8.
89. Oteo JA, Blanco JR, Ibarra V. Can we prevent tick-borne transmission disease? Enferm Infecc Microbiol Clin 2001; 19: 509-13.
90. des VF, Piesman J, Heffernan R, Schulze TL, Stafford KC III, Fish D. Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs. J Infect Dis 2001; 183: 773-8.